🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Ethan is #livingwithcancer as best he can. He wants other children with #MEN2B to be diagnosed earlier than he was. Show your support by voting for Ethan’s film to raise awareness of #MEN2B in the #CharityFilmAwards. @AmendInfo charityfilmawards.com/videos/men2b-a…

💥new online from my lab💥 Dr Julienne O'Rourke+RohanBD+Dr. Elyse Dunn discuss the mechanism of Alternative Lengthening of Telomeres, the newly discovered role for FANCM in this process, and how FANCM could be targeted in ALT cancers #openaccess link: xfe88.app.goo.gl/ALTcontrol

Awesome day today hearing about the fantastic cancer research happening in western Sydney at the Crown Princess Mary Cancer Centre Symposium. From proteomics to VR medical training and of course a bit of immunology too! Thanks for the invite!

We are in the dark on how the #COVID2019 spreads. Cannot stress more on how critical it is to test, test, test!!! We are working with ElinavLab Eran Elinav Weizmann Institute to develop a new technology for MASSIVE testing of #COVID2019. More info here: instagram.com/tv/B-MUpRhgGmd…

Principle of the Abbot #COVID-19 test. “the method is able to amplify RNA without a separate reverse transcription step.“ tandfonline.com/doi/full/10.10…

Nice news article in today’s Age with commentary from our Aussie scientists describing why COVID-19 became so virulent in humans..theage.com.au/national/the-p…

So proud to be working with such talented people on this project and to be receiving this important research funding for #unknownprimary

Excited to have the opportunity to receive MRFF funding to study a new type of PET scan to help improve diagnosis and treatment for patients with Cancer of Unknown Primary (CUP) together with fantastic team incl @UMCCR RichTothill BowtellLab

New #JITC article: Clinical, FDG-PET and molecular markers of immune checkpoint inhibitor response in patients with metastatic Merkel cell carcinoma @ShahneenSandhu ow.ly/BBqu50BUs1P

Huge thanks to co-first authors Nick Gherardin, Kelly Waldeck and Alex Caneborg and many others who generously collaborated on this study. γδ T cells in Merkel cell carcinomas have a proinflammatory profile prognostic of patient survival cancerimmunolres.aacrjournals.org/content/early/…

Just published! Our Pursuit article as a companion to our SUPER-NEXT CUP study launch this week. Thanks to all who made this a great success @kymm_sheehan Linda Mileshkin @UMCCR Peter Mac Cancer Centre Clare Fedele 🔬🎙 Unmasking cancers with hidden identity pursuit.unimelb.edu.au/articles/unmas…

JOB OPPORTUNITY: Want to join a team improving outcomes for people with cancer of unknown primary? The Rare Disease Oncogenomics (RADIO) Lab Clinical Genomics Project Coordinator is a key role to ensure the successful delivery of this life-changing study. #genomics RichTothill jobs.unimelb.edu.au/caw/en/job/908…

If you are a motivated early career bioinformatics post-doc wanting to explore whole genome sequencing of cfDNA and are interested in translational cancer research this might be the right project for you!

Massive team effort to publish our single cell (nuclei) RNA-seq study on #pheochromocytoma and #paraganglioma nature.com/articles/s4146…. Thanks to all who contributed! @UMCCR Kolling Institute Peter Mac Research 10x Genomics NeuroEndocrine Cancer Australia Pheo Para Alliance

Today is #NETCancerDay NET Cancer Day raising awareness for #NeuroendocrineCancer patients around the world. Big shout out to NET and #pheo patient advocacy groups NeuroEndocrine Cancer Australia Pheo Para Alliance NET Research Foundation. Thanks for supporting our research Rare Disease Oncogenomics (RADIO) Lab

Exciting new job opportunity for a talented research assistant to join our team at @UMCCR Rare Disease Oncogenomics (RADIO) Lab developing novel cancer diagnostics using cell free DNA. Apply now! jobs.unimelb.edu.au/en/job/914855/…

Great satisfaction to finally publish this seven years in the making A5_AdrenalAlliance SDHB study involving multi-omic analysis of #pheo #para to understand the molecular basis of metastatic progression and treatment resistance. Pheo Para Alliance url.au.m.mimecastprotect.com/s/tyW6CZYMPyC7…

A big team effort of Collaborative Centre for Genomic Cancer Medicine Peter Mac Cancer Centre Linda Mileshkin SUPER study collaborators and patients. See our recently published Nature Comms paper rdcu.be/emNWw employing clinical whole genome sequencing for diagnostically challenging #cancer of unknown primary